Could be old, could be new. That's not the point here I'd think.
What fascinates me even more is that INSM is now using these MMD references to NIH grants in their corporate presentations.
This is in my view a confirmation, given the conservative approach of INSM in their corporate comms, that the MMD trials are moving in the right direction.
Otherwise I'm quite sure they would have kept quiet about it.
Also I'd think that the new PR lady Jody Lomanzo is making her presence felt in getting INSM's strong points in the limelight.
E.
News 
Market Data 
Discover 
AI
